The novel autophagy inhibitor ROC-325 augments the antileukemic activity of azacitidine.
作者信息
Nawrocki Steffan T, Han Yingchun, Visconte Valeria, Przychodzen Bartlomiej, Espitia Claudia M, Phillips James, Anwer Faiz, Advani Anjali, Carraway Hetty E, Kelly Kevin R, Sekeres Mikkael A, Maciejewski Jaroslaw P, Carew Jennifer S
机构信息
Department of Medicine, The University of Arizona Comprehensive Cancer Center, Tucson, AZ, USA.
Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
出版信息
Leukemia. 2019 Dec;33(12):2971-2974. doi: 10.1038/s41375-019-0529-2. Epub 2019 Jul 29.
Abstract
摘要
相似文献
1
The novel autophagy inhibitor ROC-325 augments the antileukemic activity of azacitidine.
Leukemia. 2019 Dec;33(12):2971-2974. doi: 10.1038/s41375-019-0529-2. Epub 2019 Jul 29.
2
Moving beyond hydroxychloroquine: the novel lysosomal autophagy inhibitor ROC-325 shows significant potential in preclinical studies.
Cancer Commun (Lond). 2019 Nov 9;39(1):72. doi: 10.1186/s40880-019-0418-0.
3
Disruption of Autophagic Degradation with ROC-325 Antagonizes Renal Cell Carcinoma Pathogenesis.
Clin Cancer Res. 2017 Jun 1;23(11):2869-2879. doi: 10.1158/1078-0432.CCR-16-1742. Epub 2016 Nov 23.
4
Azacitidine is effective for targeting leukemia-initiating cells in juvenile myelomonocytic leukemia.
Leukemia. 2019 Jul;33(7):1805-1810. doi: 10.1038/s41375-018-0343-2. Epub 2019 Jan 24.
5
5-AZA-2'-deoxycytidine in cancer immunotherapy: a mouse to man story.
Cancer Res. 2007 Mar 15;67(6):2900-1; author reply 2901-2. doi: 10.1158/0008-5472.CAN-06-2986.
6
Decitabine and suberoylanilide hydroxamic acid (SAHA) inhibit growth of ovarian cancer cell lines and xenografts while inducing expression of imprinted tumor suppressor genes, apoptosis, G2/M arrest, and autophagy.
Cancer. 2011 Oct 1;117(19):4424-38. doi: 10.1002/cncr.26073.
7
Coordinated epigenetic regulation of autophagy and apoptosis.
Cell Cycle. 2011 Sep 1;10(17):2832-3.
8
Azacitidine-resistant SKM1 myeloid cells are defective for AZA-induced mitochondrial apoptosis and autophagy.
Cell Cycle. 2011 Jul 15;10(14):2339-43. doi: 10.4161/cc.10.14.16308.
9
Targeted delivery of microRNA-29b by transferrin-conjugated anionic lipopolyplex nanoparticles: a novel therapeutic strategy in acute myeloid leukemia.
Clin Cancer Res. 2013 May 1;19(9):2355-67. doi: 10.1158/1078-0432.CCR-12-3191. Epub 2013 Mar 14.
10
GX15-070 (Obatoclax), a Bcl-2 family proteins inhibitor engenders apoptosis and pro-survival autophagy and increases Chemosensitivity in neuroblastoma.
BMC Cancer. 2019 Oct 29;19(1):1018. doi: 10.1186/s12885-019-6195-y.
引用本文的文献
1
Aging, cancer, and autophagy: connections and therapeutic perspectives.
Front Mol Biosci. 2025 Jan 28;11:1516789. doi: 10.3389/fmolb.2024.1516789. eCollection 2024.
2
Targeting regulated cell death pathways in cancers for effective treatment: a comprehensive review.
Front Cell Dev Biol. 2024 Nov 15;12:1462339. doi: 10.3389/fcell.2024.1462339. eCollection 2024.
3
Blockage of Autophagy for Cancer Therapy: A Comprehensive Review.
Int J Mol Sci. 2024 Jul 7;25(13):7459. doi: 10.3390/ijms25137459.
4
Inhibition of autophagy antagonizes breast cancer brain metastogenesis and augments the anticancer activity of lapatinib.
Clin Transl Med. 2024 Apr;14(4):e1662. doi: 10.1002/ctm2.1662.
5
Autophagy degrades immunogenic endogenous retroelements induced by 5-azacytidine in acute myeloid leukemia.
Leukemia. 2024 May;38(5):1019-1031. doi: 10.1038/s41375-024-02250-6. Epub 2024 Apr 16.
6
Mitophagy regulates mitochondrial number following pharmacological induction of mitochondrial biogenesis in renal proximal tubule cells.
Front Pharmacol. 2024 Feb 5;15:1344075. doi: 10.3389/fphar.2024.1344075. eCollection 2024.
7
Autophagy and Glycometabolic Reprograming in the Malignant Progression of Lung Cancer: A Review.
Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231190545. doi: 10.1177/15330338231190545.
8
Advances in Understanding the Links between Metabolism and Autophagy in Acute Myeloid Leukemia: From Biology to Therapeutic Targeting.
Cells. 2023 Jun 5;12(11):1553. doi: 10.3390/cells12111553.
9
Targeting NEDDylation is a Novel Strategy to Attenuate Cisplatin-induced Nephrotoxicity.
Cancer Res Commun. 2023 Feb 13;3(2):245-257. doi: 10.1158/2767-9764.CRC-22-0340. eCollection 2023 Feb.
10
Enhancing Anti-Cancer Therapy with Selective Autophagy Inhibitors by Targeting Protective Autophagy.
Biomol Ther (Seoul). 2023 Jan 1;31(1):1-15. doi: 10.4062/biomolther.2022.153.
Zotero 插件